NeuroSense Therapeutics Ltd. (NRSN)

NASDAQ: NRSN · IEX Real-Time Price · USD

1.330

+0.070 (5.56%)

At close: May 3, 2024, 4:00 PM

1.360

+0.030 (2.26%)

After-hours: May 3, 2024, 5:55 PM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-11.28	-12.34	-4.04	-2.83	-1.22
Depreciation & Amortization	0.1	0.09	0	0	0
Share-Based Compensation	2.8	5.11	4.16	2.06	0.61
Other Operating Activities	-0.07	-0.44	-1.66	0.07	0.03
Operating Cash Flow	-8.45	-7.59	-1.54	-0.7	-0.58
Capital Expenditures	-0.03	-0.07	-0.02	-0.01	-0.01
Change in Investments	3.5	-3.52	0	0	-0.02
Other Investing Activities	0.18	0.05	-	-	-
Investing Cash Flow	3.65	-3.54	-0.02	-0.01	-0.03
Share Issuance / Repurchase	3.98	3.87	11.1	0.51	1.42
Debt Issued / Paid	-0.08	-0.08	0.8	0	-0
Other Financing Activities	-	-0.1	-	-	-
Financing Cash Flow	3.9	3.7	11.9	0.51	1.42
Exchange Rate Effect	0.01	-0.09	0.02	0	0
Net Cash Flow	-0.9	-7.52	10.36	-0.2	0.81
Free Cash Flow	-8.48	-7.66	-1.56	-0.7	-0.59
Free Cash Flow Per Share	-0.68	-0.67	-0.25	-0.13	-0.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).